Phase III Study of Gemcitabine and Cisplatin With or Without Aprinocarsen, a Protein Kinase C-Alpha Antisense Oligonucleotide, in Patients With Advanced-Stage Non–Small-Cell Lung Cancer - Concepedia

Concepedia

Publication | Closed Access

Phase III Study of Gemcitabine and Cisplatin With or Without Aprinocarsen, a Protein Kinase C-Alpha Antisense Oligonucleotide, in Patients With Advanced-Stage Non–Small-Cell Lung Cancer

155

Citations

20

References

2006

Year

Luis Paz‐Ares, Jean‐Yves Douillard, P. Koralewski, Christian Manegold, Egbert F. Smit, Jose Reyes, Gee‐Chen Chang, William J. John, Patrick Peterson, Coleman K. Obasaju,

Journal of Clinical Oncology

Abstract

Adding aprinocarsen to gemcitabine and cisplatin regimen did not enhance survival and other efficacy measures in patients with advanced NSCLC.

References

	Year	Citations

Page 1